drugset / Trial / NCT03188991
Intracystic Injection of NanoPac® in Subjects With Mucinous Cystic Pancreatic Neoplasms
Non-randomizedSequentialOpen-labelTreatment
Summary
This study will evaluate intracystic NanoPac® (Sterile Nanoparticulate Paclitaxel) administered via endoscopic ultrasound-guided fine needle injection (EUS-FNI) in subjects with mucinous cystic pancreatic neoplasms.
Timeline
- Start
- 2017-09-29
- Primary completion
- 2020-06-29
- Completion
- 2020-06-29
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Paclitaxel | Small molecule | 6 mg/ml | Other |
| Subject | Paclitaxel | Small molecule | 10 mg/ml | Other |
| Subject | Paclitaxel | Small molecule | 15 mg/ml | Other |